MCO — Moody's Corporation

The market is neutral-to-cautious after the 2026-10-21 Q3 print: revenue was flat YoY at $2.02B and adjusted EPS of $4.14 missed the $4.25 consensus, sending the stock down 3.16% to $460.33 from a $475.35 prior close. Analysts still rate it Buy with a $538.55 consensus target, but Morgan Stanley cut its target to $470, and the muted price action (RSI 50.31) shows investors waiting for issuance volumes to recover.

Revenue growth decelerated sharply: +15.1% YoY in Q2 2026, +8.1% in Q1 2026, then just +0.8% in Q3 2026 ($2.023B vs $2.007B). That Q3 slowdown came from Moody's Investors Service revenue falling 1% to $1.09B on lower leveraged-finance issuance, while Moody's Analytics grew 3% to $936M. The full-year trend is not deteriorating: operating margin held at 44.8% in Q3 2026 versus 45.7% a year earlier, net income rose 13.6%, diluted EPS rose 17.8% to $4.24, and TTM FCF is about $3.06B. Treat Q3 as a cyclical issuance air pocket, not a structural margin break, though it is a clear near-term deceleration.

As of 2026-10-21, MCO trades at 27.98x TTM EPS of $16.684 and 27.3x next-FY EPS of $16.871, below its 5-year average P/E of 38.75x and 5-year average P/S of 11.43x versus 9.75x today. PEG is 0.88, which looks cheap only if growth reaccelerates; on absolute terms, 27-28x for flat near-term EPS is fair, not bargain-bin. I'd call it cheap versus its own history but only modestly attractive versus the broader market.

At $460.33 on 2026-10-21, the stock is pricing roughly 27x FY2026 guided EPS midpoint of $16.75 and 27x FY2027 consensus of $16.87. That is not a heroic multiple for a 45%-operating-margin franchise, but it also doesn't price in a deep downturn. If Q4 confirms the Q3 issuance slump, estimates may need trimming and 27x can compress; if leveraged-finance issuance recovers, the current multiple leaves room to re-rate toward the low-30s. The key is that earnings estimates assume a reacceleration that has not yet shown up in revenue.

As of 2026-10-21, RSI was 50.31, price was 1.51% above the 20-day SMA but 1.57% below the 50-day SMA and only 0.33% above the 200-day SMA. That is range-bound, not oversold or overbought. The post-earnings drop keeps the stock near the middle of its 52-week $402.28-$546.88 range; no technical urgency to buy, and a reclaim of the 50-day would be a better confirmation than the current flat tape.

• Debt issuance volumes and the path of interest rates: MCO's ratings revenue is tied to primary bond and leveraged-finance issuance, so a rate-driven freeze or thaw in capital markets moves transaction revenue quickly.
• Private credit expansion: it creates demand for Moody's private-market risk models (e.g., the Allvue partnership) but could shift financing away from public bond issuance over time.
• AI and data-platform competition: the Google Cloud Gemini integration is a potential Analytics tailwind, but it also exposes MCO to fast-moving competition from data providers and AI-native risk tools.
• Regulatory scrutiny of credit rating agencies: the issuer-pays model and raters' role in capital markets remain subject to SEC/EU oversight and potential rule changes.
• Corporate M&A and refinancing cycles: a pickup in M&A/IPO activity and debt maturity walls would lift issuance and ratings demand; a slowdown would hit the cyclical segment.

• Q4 2026 earnings and initial FY2027 guidance, especially whether MIS revenue returns to growth after the Q3 2026 -1% YoY decline.
• Recovery in leveraged-finance and broader debt issuance as rates stabilize or fall, which would lift transaction revenue and operating leverage.
• Adoption of Moody's Analytics AI products, including the Google Cloud Gemini integration and Allvue private-credit risk model.
• Continued strong free cash flow and capital returns: TTM FCF around $3.06B supports buybacks/dividends and EPS growth even with flat revenue.

• Prolonged capital-markets slowdown: if leveraged-finance issuance stays weak, Q3 2026's flat revenue could extend and force consensus EPS cuts.
• Valuation risk: 27-28x P/E is not cheap if EPS growth stays near zero, and the 5-year average 38.75x may be an unreliable anchor in a higher-rate regime.
• Competitive and regulatory pressure in Ratings and Analytics, including AI-native data tools and potential changes to the issuer-pays model.
• Balance-sheet leverage: debt/equity is 2.29x and net debt is roughly $5.3B, leaving less room if rates stay high or a downturn pressures FCF.

MCO is a high-quality, wide-moat franchise with 44.9% operating margin, 35.3% net margin, 21% ROIC, and about $3.06B of TTM free cash flow, and at 27-28x earnings it is cheaper than its own history. But Q3 2026 showed a real cyclical air pocket in Ratings, and with EPS estimates roughly flat next year, the stock lacks a near-term catalyst; I'd call the risk/reward balanced rather than a compelling buy, and would want evidence of issuance recovery before getting more constructive.

I applied a 29x P/E multiple to next-FY consensus EPS of $16.871, a discount to MCO's 5-year average 38.75x to reflect slower near-term issuance growth and a higher-rate backdrop, but a modest premium to the current 27.3x forward multiple for its 45% operating margin and 21% ROIC. That gives 16.871 x 29 = $489.26.